Skip to content
Book Open access

MuSeL: A Multi-Scale Adaptive Graph Representation Learning Framework for Microbe-Drug Association Prediction

Aug 2026 · Proceedings of the 32nd ACM SIGKDD Conference on Knowledge Discovery and Data Mining V.2 · pp. 5512-5523 · 0 citations · 54 references

TL;DR

MuSeL is proposed, a multi-scale adaptive graph representation learning framework that jointly mitigates the above issues from two complementary perspectives: global topology modeling and local structure optimization.

Abstract

Microbe-drug association (MDA) prediction is of great importance for understanding drug action mechanisms and exploring microbiome-based therapeutic strategies. However, when confronted with extremely sparse biological networks with pronounced structural heterogeneity, existing methods often struggle to simultaneously model global topological dependencies and local structural disparities. To address these challenges, we propose MuSeL, a multi-scale adaptive graph representation learning framework that jointly mitigates the above issues from two complementary perspectives: global topology modeling and local structure optimization. Specifically, we develop a spectral kernel attention mechanism that leverages the normalized Laplacian and chebyshev polynomial expansion to efficiently capture multi-scale global topological relations in the spectral domain. Meanwhile, we construct a structure-aware self-adaptive sampling module that dynamically adjusts neighborhood sampling based on node clustering coefficients and degree centrality, thereby improving the reliability of local structural and feature representations. Finally, the fused multi-scale node embeddings are fed into a prediction module to estimate MDA scores. Extensive experiments show that outperforms existing mainstream models, while ablation studies and case analyses further validate its effectiveness and robustness. Overall, MuSeL provides a practical computational framework for prioritizing candidate MDAs, supporting downstream biological validation and drug repurposing research.

Read PDF

Similar papers

Sep 2026

Multi-view Graph Learning Framework with Spectral Encoding and Sparse Cross-Attention for miRNA-Drug Association Prediction.

Experimental results show that MVGSCA effectively integrates heterogeneous biological information and achieves superior prediction performance, offering valuable insights into cancer resistance mechanisms and supporting drug discovery efforts.

Ru Nie, Ying Fu, Zhengwei Li et al. · 0 citations
Aug 2026

IHLO-DTI: Drug-Target Interaction Prediction Based on Improved Hypergraph Neural Network and Laplacian Matrix Optimization

IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.

Guolongwei Dai, Tao Luo, Dan-Dan Li et al. · 0 citations
Open access Sep 2026

Topology-Guided Multi-Level Graph Learning: A Unified Framework for Molecular Property Prediction

Accurate molecular property prediction underpins progress in drug discovery, medicinal chemistry, and molecular design and depends critically on the quality of the learned molecular representations. While Graph Neural Networks (GNNs) and Graph Transformers have advanced this field considerably, most existing approaches...

Hasnain Ali, Momina Arshad, M. Iqbal et al. · 0 citations
Aug 2026

A Novel Graph Transformer Framework for Predicting Drug-Disease Associations with Structural Awareness.

SGTL-DDA is proposed, a novel graph transformer framework designed to incorporate structural information and domain-specific knowledge from heterogeneous biological information networks (HBINs) that successfully identifies both known therapeutics and novel repositioning candidates, supported by molecular docking result...

Bowei Zhao, Hui Zhao, Yu-An Huang et al. · 0 citations
Open access Sep 2026

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale...

Hong-Sheng Xie, Yuan Gao, Shan-Lin Ke et al. · 0 citations
Aug 2026

MKASynergy: an adaptive method for drug synergy prediction via a mixture-of-experts kernel mechanism

MKASynergy, an adaptive drug synergy prediction method based on a mixture-of-experts kernel mechanism, achieves competitive predictive performance and visualization analysis confirms the model’s effectiveness in feature decoupling and helps interpret latent drug synergistic mechanisms.

Cundong Lin, Jiancheng Ni, Ying Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.